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Abbreviations
LDLT Living donor liver transplantation
LLD Living liver donation
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Sports and military heroes frequently receive extensive public praise and admiration for their 
exceptional performance and acts of bravery. In that vein, an individual who donates a part of their liver to a 
family member or close friend is a medical “hero” to the recipient as well as the broader community. Living 
liver donors (LLDs) voluntarily agree to incur substantial personal risk (i.e. mortality of 1 in 250 to 1 in 500) 
in an effort to help a fellow human being in dire need of a life-saving liver transplant. Not surprisingly, 
living liver and kidney donors have a higher level of resilience and perseverance to overcome adversity when 
compared with population controls1 . Although liver donors experience significant postoperative pain and up 
to 3 months of functional disability and lost wages, they are not financially incentivized nor recognized 
for their good deeds. However, the majority of living donors are rewarded by their sense of self-fulfillment and 
gratification that persists for many years after donation.2
Since the annual number of adult- to-adult living donor liver transplants (LDLT) is limited, the frequency, 
type, and severity of complications among donors are not well known nor are the donor or recipient features 
associated with adverse outcomes. Medical risks within the first year of donation include biliary complications 
(20%), infections (20%-30%), and need for reoperation (5%-10%)3,4 . In addition, there are rare reports of 
severe psychiatric complications in adult liver donors that may occur remote from  transplant5 . In this 
issue, investigators from New York help improve our understanding of the longterm health and functional 
outcomes of adult LLD6 . The data in this study arose from a statewide quality-assurance effort that was 
initiated in New York in 2004 and included the development of a liver-donor-specific questionnaire to 
assess 7 quality-of-life domains.
The 220 liver donors in the current report expand our understanding of functional outcomes previously 
reported by the Adult to Adult Living Donor Transplantation Cohort Study (A2ALL) and from Toronto2, 7 (Table 
1). Notable strengths of this multicenter report include the high rate of eligible participant involvement over 6 
years (70%) and the ability to extract new issues and concerns over time by a combination of multiple choice 
and open-ended telephone survey questions. Study limitations include the lack of baseline donor psychosocial 
profiles, information regarding the type of LLD performed and recipient outcomes which could significantly 
impact donor views and perceptions. Furthermore, the lack of a paired comparison of individual patients over 
time could have substantially underestimated the frequency and severity of complications. Nonetheless, the 
majority of LLD reported high rates of willingness to donate again (>90% through year 5 postdonation), feeling 
“very satisfied” after donation (81%-88% over time), and an increased positive outlook and self-worth related to 
LLD (82%). Interestingly, all of this positivity occurred in a cohort that also incurred substantial financial 
expense with 12% having spent >$3000 for LLD-related expenses and 8% reporting that donation was a major 
financial hardship for them. In addition, 28% reported abdominal incisional pain negatively impacting their 
quality of life and 21% did not return to their predonation occupation for unspecified reasons. Overall, these 
data are generally reassuring to transplant teams with the low rate of severe or unexpected medical sequelae 
after 1 year and may help inform administrators and policy makers of the substantial nonmedical costs 
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associated with LLD.
Concerning new insights provided by Rudow et al. include the sizable rates of post-LLD emotional 
distress reported in this otherwise highly selected and resilient population of healthy donors. While 70% of the 
cohort reported no emotional distress during follow-up, 6% to 12% of donors consistently reported emotional 
problems at 2 to 6 years of follow-up. Unfortunately, the reported emotional symptoms (anxiety, intrusive 
thoughts, depression) were not well characterized nor confirmed by a clinician. Furthermore, it is not clear if 
these emotional issues were related to liver donation, recipient outcomes, or other life circumstances. 
Nevertheless, the finding that no donors had received any type of counseling or therapy is of concern and 
highlights the need for more careful assessment and monitoring of LLD after initial recovery from donation.
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The annual number of adult-to-adult LDLT will likely increase over the next decade given recent changes to 
deceased organ donor allocation policy and concomitant advances regarding the overall safety profile of partial 
hepatectomy. In particular, the potential use of laparoscopic surgical techniques could reduce both short- and 
longterm donor morbidity including incisional hernias as has been seen with living kidney donation. In the 
interim, there are several ways in which our understanding of the safety and efficacy of LLD can be improved. 
First, the Organ Procurement and Transplantation Network and other international regulators now mandate 
reporting of various medical and psychosocial complications among liver donors at the time of hospital 
discharge and at 6 months, 1 year, and 2 years after donation8,9 . However, the content and duration of follow- 
up in these national data reports may not be detailed enough to detect and respond to crucial nuances in 
donors’ health and functional status. Expanded prospective medical and radiological assessments are 
therefore needed to detect occult portal hypertension and vascular/ biliary complications as well as changes in 
donor nutrition and fertility during longterm follow-up. In addition, baseline and follow-up assessments using 
validated psychometrics are needed to provide higher resolution data on emotional health and adjustment over 
time. Finally, studies of functional outcomes in LLD lack appropriate comparator groups and would benefit 
from the inclusion of controls such as LLD candidates evaluated at the same center but excluded on 
anatomical grounds.
Liver transplant programs are continuously challenged to maintain equipoise between living donor 
safety and the mortality risk to wait-listed patients. The work of Rudow et al. provides important new 
information to help educate potential donors of the longterm risks and benefits of LLD6 . As we screen 
potential donors and communicate detailed risk and benefit information to them, we must now also carefully 
counsel and guide them regarding their future longterm health risks and potential financial challenges if they 
are unable to return to their predonation occupation. In addition, this study highlights the need for additional 
resources and studies to monitor, assess, and treat individual liver donors who develop clinically significant 
emotional distress after the spotlight of their selfless act of donor heroism fades from our memories.
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Table 1 - Studies of long-term outcomes in adult LDLT donors
Rudow et al (6) Dew et al (2) Adcock et al (7)
Study Characteristics
Description qualitative methods, LLD-
specific questionnaire
Multicenter, prospective
longitudinal; quantitative and
Multicenter, cross-sectional, 
telephone survey
chart review; detailed medical
Single center, retrospective
and psychosocial data
Population 
(Years of data)
6 centers in New York 
(2004-2013)
9 North American centers 
(2002-2009)
Toronto 
(2000-2008)
# Participants (% eligible) 220 (72%) 517 (66%) 202 (82%)
Median age at donation 
(years)
41 
(20-62)
Not reported 
(19-61)
37 (18 to 60)
% Female 56 % 53 % 47%
% Married Not reported 71% 57 %
% Employed 81% 87% 92%
Duration of follow-up (yrs) Annually for 6 years Mean = 6 yrs 
All > 3 years post-LDL
Mean = 2.8 yrs
Key Findings
Medical concerns 66% > 1 LLD-related medical 
problem
22% abdominal pain at yr 3
28% pain negatively affect 
69% wound numbness
50% decreased abdominal 
wall tone
36% low back pain
41% overall complication rate
7% readmission between 1 
and 12 mon
Psychological/ social 
benefits
95% resumed normal 
activities at 1 yr
90-95% would donate again
81-88% “very satisfied”
82% reported increased 
positive outlook/self-worth 
78% of employers “very 
>90% would donate again
All HRQOL measures above 
US population norms
Low levels of guilt, 
responsibility in 91 donors 
whose recipient died
HRQOL similar/better on 
physical domains, 
100% employed donors 
returned to work post-LLD 
(mean= 10 weeks)
62% in stable relationships 
7 donors married; 3 divorced;
3 widowed
Psychiatric/ functional 
concerns
 21% had different job
16% emotional issues at 1 
year
6-12% emotional issues at 2- 
6 years
12% out-of-pocket LLD 
58% LLD-rel ted expenses; 
15% burdensome
 22% unable to complete prior 
physical tasks
11% life insurance problems
Men 6x higher risk of poor 
4% female donors new or 
recurrent Depression/ anxiety
HRQOL – health-related quality of life, LDLT – living donation liver transplantation, LLD – living liver donation, MCS – mental component summary, 
MDE – major depressive episode, MH – mental health,– quality of life, SF-36 – short form 36,
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